AKT2 is a downstream target of metabotropic glutamate receptor 1 (Grm1)
Open Access
- 20 October 2009
- journal article
- research article
- Published by Wiley in Pigment Cell & Melanoma Research
- Vol. 23 (1), 103-111
- https://doi.org/10.1111/j.1755-148X.2009.00648.x
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Deregulated Akt3 Activity Promotes Development of Malignant MelanomaCancer Research, 2004
- New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathwayProceedings of the National Academy of Sciences of the United States of America, 1999
- CREB Is a Regulatory Target for the Protein Kinase Akt/PKBPublished by Elsevier BV ,1998
- The lipid phosphatase activity of PTEN is critical for its tumor supressor functionProceedings of the National Academy of Sciences of the United States of America, 1998
- Negative Regulation of PKB/Akt-Dependent Cell Survival by the Tumor Suppressor PTENCell, 1998
- The Role of IGF-I in Human Skin and its Appendages: Morphogen as Well as Mitogen?Journal of Investigative Dermatology, 1997
- Transformation of hematopoietic cells by BCR/ABL requires activation of a PI-3k/Akt-dependent pathwayThe EMBO Journal, 1997
- Amplification of AKT2 in human pancreatic cells and inhibition of AKT2 expression and tumorigenicity by antisense RNA.Proceedings of the National Academy of Sciences of the United States of America, 1996
- Molecular alterations of the AKT2 oncogene in ovarian and breast carcinomasInternational Journal of Cancer, 1995
- Molecular cloning of the akt oncogene and its human homologues AKT1 and AKT2: amplification of AKT1 in a primary human gastric adenocarcinoma.Proceedings of the National Academy of Sciences of the United States of America, 1987